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ABSTRACT Activation of Akt-mediated signaling pathways is crucial for survival, differentia-
tion, and regeneration of muscle cells. A proteomic-based search for novel substrates of Akt 
was therefore undertaken in C2C12 murine muscle cells exploiting protein characterization 
databases in combination with an anti–phospho-Akt substrate antibody. A Scansite database 
search predicted Ankrd2 (Ankyrin repeat domain protein 2, also known as ARPP) as a novel 
substrate of Akt. In vitro and in vivo studies confirmed that Akt phosphorylates Ankrd2 at 
Ser-99. Moreover, by kinase assay with recombinant Akt1 and Akt2, as well as by single-
isoform silencing, we demonstrated that Ankrd2 is a specific substrate of Akt2. Ankrd2 is 
typically found in skeletal muscle cells, where it mediates the transcriptional response to 
stress conditions. In an attempt to investigate the physiological implications of Ankrd2 phos-
phorylation by Akt2, we found that oxidative stress induced by H2O2 triggers this phospho-
rylation. Moreover, the forced expression of a phosphorylation-defective mutant form of 
Ankrd2 in C2C12 myoblasts promoted a faster differentiation program, implicating Akt-
dependent phosphorylation at Ser-99 in the negative regulation of myogenesis in response 
to stress conditions.
INTRODUCTION
The 67-kDa serine/threonine kinase Akt was originally identified 
as the cellular homologue of the v-akt oncogene (Bellacosa et al., 
1993). Akt, also known as protein kinase B (PKB), is an essential en-
zyme in all eukaryotes and is involved in a wide variety of cellular 
functions, including proliferation, cell survival, differentiation, glu-
cose mobilization, homeostasis, cell migration, and apoptosis.
Three isoforms of Akt exist, namely Akt1/PKBα, Akt2/PKBβ, and 
Akt3/PKBγ (Brazil et al., 2004), sharing a high degree of amino acid 
identity and the same ways of activation. Once activated, Akt is dis-
tributed in all cellular compartments (Andjelkovic et al., 1997), where 
it phosphorylates its substrates. Groundbreaking experiments con-
ducted in the past (Alessi et al., 1996) with peptides containing vari-
ants of the first direct target of Akt, identified on a specific residue 
of the GSK3 kinase (Cross et al., 1995), defined the minimal recogni-
tion motif of Akt as R-X-R-X-X-pS/T-B (Alessi et al., 1996), where R is 
an arginine, X is any amino acid, and B represents bulky hydropho-
bic residues.
Akt-phosphorylated substrates are involved in a variety of cel-
lular functions spanning from cell growth and survival (modulating 
proapoptotic and antiapoptotic transcription factors) to cell mi-
gration and invasion, from cellular metabolism to angiogenesis 
(reviewed in Manning and Cantley, 2007). By using a functional pro-
teomic approach, recently our laboratory identified Lamin A/C as a 
novel Akt nuclear substrate, implicating the phosphorylation of 
Lamin A/C by Akt in the correct functioning of the nuclear lamina 
(Cenni et al., 2008).
Skeletal muscle is a tissue highly responsive to Akt: Akt action 
has been linked to skeletal muscle development, regeneration, and 
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hypertrophy through several pathways that culminate in stimula-
tion of protein synthesis, inhibition of atrophy, and prevention of 
cell death (Glass, 2003; Hoffman and Nader, 2004). The function 
of the single Akt isoforms has been extensively studied in skeletal 
muscle also. This tissue revealed specialized roles for IRS-1/Akt2 
and IRS-2/Akt1 in glucose and lipid metabolism (Bouzakri et al., 
2006). In 2002, Sumitani and colleagues demonstrated that 
Akt1 and Akt2 differently regulate muscle creatine kinase and 
myogenin gene transcription in differentiating C2C12 myoblasts 
(Sumitani et al., 2002). Later, by a small RNA interfering approach, 
Heron-Milhavet reached the conclusions that Akt1 only stimulates 
cell proliferation, whereas Akt2 appears to be involved in cell 
cycle exit (Heron-Milhavet et al., 2006). This result had been ex-
tensively supported by other studies (Vandromme et al., 2001; 
Al-Khalili et al., 2004; Rochat et al., 2004). More recently, however, 
Wilson and colleagues have demonstrated that both Akts are nec-
essary for full myoblast differentiation and maturation. In particu-
lar, in C2C12 myoblasts, the loss of Akt1 blocked muscular differ-
entiation at its earliest stages, preventing induction of 
muscle-specific proteins and inhibiting formation of multinucle-
ated myofibers. On the contrary, myoblasts lacking Akt2 differen-
tiated normally, although resultant myofibers were thinner and 
incorporated fewer nuclei than controls (Wilson and Rotwein, 
2007; Rotwein and Wilson, 2009).
The MARP (muscle ankyrin repeat pro-
tein) family consists of three proteins, namely 
Ankrd1 also known as cardiac ankyrin repeat 
protein, expressed in cardiac muscle, 
Ankrd2, also called ARPP expressed in skel-
etal and cardiac muscle, and Ankrd23 or 
DARP which is found in both skeletal and 
cardiac muscle but is also up-regulated in 
type 2 diabetes. All MARPs are primarily in-
volved in the defense of the cells against 
injuries, following a prolonged muscle exer-
cise, in response to acute exercise, or during 
work overload hypertrophy. A role for these 
proteins also has been described in patho-
logical conditions, including tumors, diabe-
tes, or a number of muscular dystrophies 
(Miller et al., 2003). Our data establish 
Ankrd2 as a new signaling target of Akt2, 
and indicate this phosphorylation to be in-
volved in muscle differentiation following 
oxidative stress.
RESULTS
Identification of Ankrd2/ARPP as an 
Akt substrate in C2C12 muscle cells
To identify muscular proteins phosphory-
lated by Akt, crude lysates from C2C12 
myoblasts at different days of myogenic dif-
ferentiation (from day 0 to day 7) were as-
sayed with an antibody specifically raised 
against the Akt consensus phosphorylation 
motif, the specificity of which has been 
widely demonstrated (Alessi et al., 1996; 
Zhang et al., 2002). Through this biochemi-
cal approach, several differentiation-respon-
sive proteins were detected (Figure 1A); 
however, we focused on proteins phospho-
rylated during the earliest stages of muscle 
differentiation, when the outcome of the entire differentiation pro-
cess may be most affected. Indeed, it was especially during this 
stage that the highest activation of Akt was observed (Figure 1A; 
WB: anti–phospho-Akt substrates). In particular, at day 1 (d1), 11 pro-
teins were evidently phosphorylated. Starting from the average mo-
lecular weight assigned to each of these phosphoproteins (calculated 
as described in Materials and Methods) a Scansite analysis (http://
scansite.mit.edu/dbsequence_one.html) was performed. The search 
was carried out on a SWISS-PROT database specific for both mus 
musculus and muscular tissue proteins, querying the presence of a 
high-stringency Akt consensus phosphorylation motif, that is, [R][A-Z]
[R][A-Z][A-Z][S/T], phosphorylated at serine or threonine. This study 
resulted in a short list of potential Akt substrates, shown in Table 1.
To further narrow the number of potential Akt substrates, protein 
extracts from d1 differentiating C2C12 myoblasts were fractionated 
by their isoelectric point (PI) by a MicroRotofor device, and the resul-
tant protein fractions were probed for the presence of phospho-Akt 
substrates.
We reasoned that the phosphoprotein focusing at a PI value 
of approximately 6 and with a molecular weight of approximately 
39 kDa, which correspond to Ankrd2, a muscle specific protein.
The membranes of the experiments just mentioned were there-
fore incubated with an anti-Ankrd2 specific antibody. Figure 1, A 
and B (bottom panels), shows that the 39-kDa band, recognized by 
FIGURE 1: Akt phosphorylates Ankrd2. (A) Cycling C2C12 cells were grown to confluence and 
allowed to differentiate from d0 to d7 in the presence of differentiating medium. Cell extracts 
were immunoblotted with the anti–phospho-Akt substrates (anti P-Akt sub) antibody. 
Anti-Troponin T and -β tubulin antibodies were used as differentiation and equal loading 
markers, respectively. Asterisks highlight bands significantly more phosphorylated at d1 of 
differentiation. Line graph demonstrates the average fold change in phosphorylation, 
determined as the ratio in the change of Akt-phosphorylated Ankrd2 vs. the amount of total 
Ankrd2 of the lysates of A and indicates that Ankrd2 phosphorylation by Akt peaks at d1. 
(B) Top, lysates from d1-differentiating C2C12 myoblasts were focused with a MicroRotofor 
device and probed with the anti–phospo-Akt substrates antibody. Nitrocellulose was then 
stripped and incubated with an anti-Ankrd2 specific antibody (bottom panel).
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scanned by the Scansite databases for Akt consensus phosphoryla-
tion motifs. In good agreement with the results presented earlier in 
this article, this search produced a putative Akt phosphorylation site 
mapping at Ser-99 of the human sequence.
Therefore HEK 293T cells, which do not express endogenous 
Ankrd2, were transfected with either wild type (WT) or mutant 
Ser99Ala human flag-tagged Ankrd2. Then, pellets of immunopre-
cipitated flag-Ankrd2 were mixed with recombinant active Akt1 or 
Akt2 for in vitro kinase assay. As control, the activity of the kinases 
was assayed using myelin basic protein. The results show that both 
Akt1 and Akt2 failed to phosphorylate Ser99Ala Ankrd2, indicating 
Ser-99 as an authentic Akt phosphorylation site (Figure 2A). 
the anti–phospho-Akt substrate antibody, perfectly merges with that 
of the anti-Ankrd2. Moreover, although Ankrd2 expression increases 
with differentiation, as reported previously by other laboratories 
(Ishiguro et al., 2002), it is worth noting that its phosphorylation 
peaks at d1 (Figure 1A, line graph). Finally, Figure 1B shows that 
Ankrd2 drops in two contiguous fractions, suggesting different 
phosphorylation degrees.
Ser-99 of Ankrd2 is a substrate of Akt both in vitro  
and in Akt-activated cultured cells
To identify the putative site(s) of Ankrd2 phosphorylated by Akt, 
Ankrd2 complete amino acidic sequences cloned so far were 
No. Average Mass1 Acc. Numb2 Name2 Predicted Mass2 PI3 Akt motif* Function2
1 272–301 Q8BTM8 FLNA 281.194 5.65 m/l motif Actin binding protein
2 209–231 Q61879 MYH10 228.996 5.42 RQRHAT1203A Cellular myosin
O08638 MYH11 227.028 5.36 RVRKAT1763L Myosin heavy chain, smooth 
muscle isoform
Q6URW6 MYH14 228.586 5.48 m/l motif Cellular myosin
Q5SX40 MYH1 223.342 5.58 m/l motif Adult skeletal muscle myosin
A2AQP0 MYH7B 221.497 5.67 m/l motif Cardiac myosin
P13542 MYH8 222.708 5.63 m/l motif Muscle specific perinatal 
myosin
Q99104 MYH5A 215.595 8.79 RKRTSS1650I Cellular myosin
Q9JJV9 SCN5A 227.622 5.43 m/l motif Cardiac specific voltage-gated 
sodium channel
3 77–86 P33146 CAD15 85.660 4.64 m/l motif Muscle specific cell adhesion 
protein
Q8BU25 PAMR1 80.378 6.79 RRRVLS361M Inactive peptidase involved in 
muscle regeneration
Q61321 SIX4 77.203 5.76 m/l motif DNA binding protein involved 
in skeletal muscle development
82.263 5.55 m/l motif
4 68–79 Q9WTL8 BMAL1 69.452 6.04 RKRKGS42A 
RSRWFS428F
Transcription cofactor
5 59–65 Q2VPD4 BMAL2 64.399 7.96 m/l motif Transcription coactivator
Q3UZD5 PRDM6 64.503 7.55 RPRPAS79L Smooth muscle specific histone 
methyltransferase
6 55–60 Q9JIF9 MYOTI 55.316 8.85 m/l motif Component of a complex of 
actin cross-linkers
7 53–59 Q9JIF9 MYOTI 55.316 8.85 m/l motif Component of a complex of 
actin cross-linkers
8 49–55 P46664 PURA2 50.021 5.85 m/l motif Purine nucleotide biosynthesis 
enzyme
9 36–40 Q9WV06 ANKRD2 39.858 6.1 RVRKTS98L Structural and gene regulatory 
protein
Q9JLH8 TMOD4 39.261 4.72 m/l motif Actin capping protein
Q38HM4 TRI63 39.491 4.8 m/l motif Muscle specific ubiquitin
10 28–31 No matching found
1Estimated mass (expressed in kilodaltons) according to the Quantity One 1D Software, Bio-Rad. 2Font: UniProtKB/Swiss-Prot. 3Scansite calculation of PI following 
one phosphorylation event.
*High-stringency scan for Akt motifs performed on Scansite. Medium- or low-stringency Akt motifs (m/l motif) not reported. Entries in bold were obtained from 
musculoskeletal protein database and therefore indicate musculoskeletal proteins.
TABLE 1: Mus musculus and musculoskeletal specific proteins matching the phosphorylation motif profile for the Ser/Thr protein kinase Akt.
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Conversely, recombinant Akt2 phosphorylates Ankrd2 to a much 
greater extent than does Akt1, indicating a preference of this sub-
strate toward Akt2 (Figure 2A).
Next Ankrd2 phosphorylation by Akt was monitored in vivo. 
HEK 293T cells were transfected with WT or Ser99Ala–flag-
Ankrd2. After 1 d of serum starvation, cells were treated with in-
sulin to activate Akt, and the phosphorylation state of Ankrd2 
was monitored by Western blot by the phospho-Akt substrate 
antibody. Figure 2, B and C, shows that insulin leads to phospho-
rylation of Ankrd2 by Akt. Confirming the data presented earlier 
in the text, and validating the antibody specificity, the immunore-
activity is undetectable in unphosphorylatable Ser99Ala samples 
(Figure 2C).
Remarkably, a recent proteomic study published by Moritz et al. 
in Science Signaling (Moritz et al., 2010), in which the anti–phospho-
Akt substrate antibody was used to capture peptides phosphory-
lated by this kinase, predicted Ser-99 of Ankrd2 as a phosphoryla-
tion site for Akt. This work provides further evidence that Ser-99 also 
is phosphorylated by Akt in in vivo cellular models.
To confirm the specificity of Akt-dependent Ankrd2 phosphory-
lation, HEK 293 cells were pretreated with specific inhibitors of se-
lected kinases and then treated with insulin to activate Akt. As shown 
in Figure 2C, the use of the Akt broad inhibitors perifosine and Akt 
inhibitor IV completely prevented Ankrd2 phosphorylation. Con-
versely, the MEK1/2 pathway inhibitor PD-98059 did not interfere 
with Ankrd2 phosphorylation by Akt (unpublished data). Moreover 
p70 S6 kinase-1, an AGC kinase downstream of PI3K, which shares 
the Akt consensus phosphorylation motif, did not signal to Ankrd2, 
because treatment with rapamycin (a specific inhibitor of the S6K 
upstream kinase, mTORC1; Hong et al., 2008), had no effect on 
Ankrd2 phosphorylation after insulin stimulation (Figure 2C).
To get more insight into the Akt isoform specificity of Ankrd2 
phosphorylation, additional experiments were performed with spe-
cific inhibitors. Flag-Ankrd2–expressing HEK 293T cells were treated 
with Akt1/2 or Akt2 selective inhibitors (respectively, Akt inhibitors 
VIII and XII) and were stimulated with insulin. Then lysates were 
probed for phosphorylated Ankrd2. The results showed that pretreat-
ment with either Akt1/2 or Akt2 specific inhibitors almost completely 
FIGURE 2: Akt phosphorylates Ankrd2 at Ser-99 in vitro and in HEK 293T cells. (A) In vitro Akt kinase assay. HEK 293T 
cells, which do not endogenously express Ankrd2, were transfected with flag-tagged WT or S99A Ankrd2 and then 
recovered in serum-free medium for 24 h. Overexpressed Ankrd2 forms were then immunoprecipitated by an anti-flag 
antibody. Immunoprecipitates were used as substrates for an in vitro kinase assay with [γ32]P-ATP and recombinant 
active Akt1 (+Akt1) or Akt2 (+Akt2) or kinase buffer alone (–). As control, the activity of each Akt isoform was also 
monitored on myelin basic protein. Reactions were resolved on SDS–PAGE and blotted on nitrocellulose. (B) HEK 293T 
cells were transfected with flag-Ankrd2, serum starved for 24 h, and stimulated with 1.6 μM insulin for the indicated 
times. Cell extracts were resolved on SDS–PAGE and subjected to immunoblotting with the indicated antibodies. 
(C) HEK 293T cells were transfected with flag-Ankrd2 WT or S99A as indicated, serum starved for 24 h, and treated with 
insulin or vehicle for 30 min. Where indicated before insulin, cells were also pretreated with the inhibitors for Akt 
(perifosine and inhibitor IV) and p70 S6K (rapamycin). Lysates were resolved on SDS–PAGE and subjected to 
immunoblotting with the indicated antibodies. Activities of the inhibitors were checked by the use of antibodies 
directed against anti–-phospho Akt Ser473 (Cell Signaling) and -phospho p70 S6K Ser411 (Santa Cruz Biotechnology). 
(D) HEK 293T cells were transfected with flag-Ankrd2 WT, serum starved, and treated with insulin. Where indicated, cells 
were pretreated with Akt1/2 and Akt2 specific inhibitors. Akt1 and Akt2 were separately immunoprecipitated from cell 
lysates by the use of specific antibodies, and the corresponding immunocomplexes were resolved on SDS–PAGE, 
blotted, and probed with the indicated antibodies.
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prevented phosphorylation of Ankrd2 as detected in the cell lysate 
by anti–phospho-Akt substrates (Figure 3D, anti P-Akt sub), despite 
residual Akt1 activity in Akt2 inhibitor–treated cells (Figure 2D), sup-
porting the finding that Ankrd2 is a specific substrate of Akt2. In-
deed, it is worth noting that Ankrd2 was detectable only in pellets 
from Akt2, but not Akt1, immunoprecipitates (Figure 2D).
Akt interacts with Ankrd2 also in vivo
To further confirm the data just presented, short hairpin RNA (shRNA) 
targeting either Akt1 or Akt2 was introduced into HEK 293T cells 
expressing flag-Ankrd2. After activating Akt by insulin stimulation, 
Ankrd2 was immunoprecipitated and the immunocomplexes 
searched for the presence of phosphorylated Ankrd2. As shown in 
Figure 3A, the knock down of Akt2 nearly abrogated insulin-induced 
Ankrd2 phosphorylation. Conversely, depletion of Akt1 had minimal 
effects. Next HEK 293T cells were cotransfected with WT Ankrd2 
together with each Akt isoform, followed by immunoprecipitation 
with anti-flag antibody. The results in Figure 3B reveal that Ankrd2 
robustly associates with Akt2. Of note, Ankrd2 does not bind Akt3 
and weakly binds Akt1 (Figure 3B, lane 1).
Finally, to assess whether Akt activity is essential for its binding to 
Ankrd2, Akt2 association to Ankrd2 was monitored in insulin-treated 
cells. Confirming the findings presented earlier in the text, the inter-
action is indeed strongly increased upon Akt activation (Figure 3C).
Although Akt3 is expressed in HEK 293T (and C2C12 cells), it 
is unlikely to contribute to Ankrd2 regulation, because overex-
pressed Akt3 does not bind to Ankrd2 and Akt2 shRNA signifi-
cantly reduces Ankrd2 phosphorylation.
H2O2 is a physiological activator 
of Ankrd2 phosphorylation by Akt 
in C2C12 cells
Ankrd2 belongs to the MARP family, which 
members are all involved in the cellular re-
sponse to stress conditions (Proske and 
Morgan, 2001). Therefore we asked whether 
reactive oxygen species (ROS), which can 
signal through the PI3K/Akt axis (Shaw et al., 
1998), might affect Ankrd2 phosphorylation 
by Akt.
C2C12 myotubes were exposed to H2O2 
(450 μM final concentration) from 5 min to 
5 h, and the phosphorylation of Ankrd2 by 
Akt was probed by Western blot in total cel-
lular lysates. Figure 4A reveals that the arrival 
of H2O2 induces a huge and sustained Akt 
activation, concomitantly to an increase of 
Akt-dependent Ankrd2 phosphorylation. 
This last observation came after probing the 
anti–phospho-Akt substrate antibody on to-
tal cell lysates and on Ankrd2-immunopre-
cipitates, both obtained from myotubes ex-
posed to H2O2 (Figure 4A, WB: P-Akt sub, 
and Figure 4B, IP: α-Ankrd2, WB: α-P-Akt 
sub). To further support these findings, the 
phospho-Akt substrates immunoprecipitated 
from the lysates just mentioned were re-
solved by SDS–PAGE and then revealed with 
anti-Ankrd2. In agreement with the data just 
presented, Figure 4B demonstrates that the 
amount of Ankrd2 phosphorylated by Akt is 
robustly increased by H2O2 (Figure 4B, IP: 
α-P-Akt sub, WB: α-Ankrd2). Furthermore, 
Ankrd2 immunoprecipitates from H2O2-treated C2C12 myotubes 
were probed with anti-Akt, demonstrating that oxidative stress con-
ditions induced by H2O2 also promote association of endogenous 
Ankrd2 to Akt (Figure 4B, IP: α-Ankrd2, WB: α-Akt and vice versa).
Of note, Figure 4A also demonstrates that, concomitantly with 
Ankrd2 phosphorylation, cyclin D3, a key regulator of the differenti-
ated phenotype (Cenciarelli et al., 1999), is strongly down-regulated 
following H2O2 stimulation.
C2C12 myotubes were then pretreated with selective inhibitors of 
Akt1/2 and Akt2 (Figure 4C) and exposed to H2O2 for 15 min. 
Ankrd2 was immunoprecipitated from C2C12 myotube lysates, and 
the pellets were probed with the phospho-Akt substrate antibody. 
As previously observed, both Akt1/2 and Akt2 inhibitors were able 
to abrogate Ankrd2 phosphorylation (Figure 4C, IP: α-Ankrd2, WB 
α-P-Akt sub), despite the residual Akt1 activity in cells treated with 
Akt2 specific inhibitor (Figure 4C, IP: α-Akt1, WB: α-P-Akt).
We conclude therefore that, following H2O2 stimulation, also 
in C2C12 myotubes, Ankrd2 is specifically phosphorylated by Akt 
isoform 2.
Oxidative stress induces nuclear translocation of Ankrd2
An analysis from the wolfpsort data set (http://www.wolfpsort.org) 
predicts Ankrd2 localization as 11.5% nuclear, 11.5% cytoplasmic, 
and 14.5% cytonuclear, thus indicating the possibility of localizing to 
both the cytosol and/or the nucleus without distinguishing between 
conditional and constitutive dual localization. To monitor Ankrd2 lo-
calization following stress stimulation, cytoplasmic and nuclear frac-
tions obtained from C2C12 cells exposed to H2O2 were checked for 
FIGURE 3: Ankrd2 is an Akt2 specific substrate. (A) HEK 293T cells expressing flag-wild-type 
(wt) Ankrd2 were infected with Akt1 or Akt2 shRNA lentiviral vector or empty vector for 24 h. 
Cells were then serum starved and stimulated with insulin for 30 min before addition of lysis 
buffer. Ankrd2 was then immunoprecipitated from total cell lysates by anti-flag antibody, and 
pellets were resolved on SDS–PAGE and subjected to immunoblot analysis. Western blot 
directed against Akt –1 and –2 of total lysates confirms Akt specific isoform silencing. (B) HEK 
293T cells were cotransfected with flag-Ankrd2 wt and HA-Akt –1, –2, or –3. Cellular extracts 
were subjected to immunoprecipitation by an anti-flag antibody. Obtained precipitates and 
corresponding lysates were resolved on SDS–PAGE and immunoblotted with an anti–HA 
antibody to check the Akt isoform bound to Ankrd2. (C) HEK 293T cells were cotransfected with 
HA-Akt2 and wt or S99A forms of flag-Ankrd2. Cells were serum starved for 24 h and treated 
with 1.6 μM insulin for 30 min. Cells extracts were immunoprecipitated with anti-flag antibody 
and immunoblotted with the indicated antibodies.
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the presence of endogenous Ankrd2. The results, shown in Supple-
mental Figure S1, indicate that Ankrd2 is located both in the cyto-
plasm and in the nuclei of differentiating C2C12. The arrival of the 
stimulus, however, promotes Ankrd2 to accumulate into the nucleus. 
In particular, Ankrd2 nuclear accumulation becomes increasingly 
evident over time, reaching a percentage of 70% at 3 h from the 
administration of H2O2.
Next cellular localization of both the WT and phosphorylation-
defective mutant was checked. C2C12 cells were transfected with 
flag-tagged WT or Ser99Ala Ankrd2, seeded on slides, and allowed 
to differentiate for 1 d. Slides were fixed and incubated with anti–
flag antibody for immunofluorescence analysis. Figure 5B, top 
panel, shows that, in differentiating myoblasts, WT and Ser99Ala 
Ankrd2 have a similar localization, being distributed both in the cy-
toplasm and, to a much lesser extent, in the nucleus. We further 
analyzed the myotube formation by counting the multinucleated 
cells after the transfection. As shown in Figure 5C, transfection of 
the unphosphorylatable Ser99Ala mutant unexpectedly increased 
the number of myotubes having two to four nuclei, compared with 
untransfected or empty vector–transfected cells, or with WT Ankrd2–
overexpressing cells in which the myotube formation was signifi-
cantly lower (Figure 5C).
Coverslip-attached myotubes were then exposed for 3 h to 
450 μM H2O2 and processed for immunocytochemical analysis. As 
shown in Figure 5A, the arrival of the stimulus induces Ankrd2 to 
concentrate in the nuclear and perinuclear region. In contrast, the 
phosphorylation-defective mutant was unable to redistribute into 
the nucleus upon H2O2 exposure (Figure 5A).
Next, by means of cell fractionation we tried to determine in 
which subcellular compartment Ankrd2 associates to and is phos-
phorylated by Akt. Nuclear and cytosolic lysates, obtained from dif-
ferentiating C2C12 myotubes exposed to H2O2 or left untreated, 
were subjected to immunoprecipitation with anti Ankrd2 antibody. 
Immunocomplexes and their corresponding lysates were resolved 
on SDS–PAGE and checked with antibodies against phospho-Akt 
substrates, Ankrd2, phospho-Akt or Akt. Confirming data in Supple-
mental Figure S1 and Figure 5C show that the amount of Ankrd2 in 
the nucleus increases upon H2O2 stimulation, being almost absent 
in unstimulated nuclei. Of note, Akt-phosphorylated Ankrd2 was 
found in both the nuclear and the cytosolic fractions.
Furthermore, a trace amount of Akt resides in the nucleus in 
the absence of stimulus and, similarly to its cytosolic counterpart, 
nuclear Akt activity is enhanced by H2O2. Despite this, only the 
cytosolic fraction of Ankrd2 is able to bind to Akt, suggesting that 
FIGURE 4: H2O2 is a physiological activator of Ankrd2 phosphorylation by Akt2 in C2C12 cells. (A) Whole lysates from 
D1-differentiated C2C12 cells exposed to H2O2 450 μM for the indicated times were resolved on a 12% SDS–PAGE and 
immunoblotted. Akt activation following H2O2 exposure was monitored by the anti Phospho-Akt Ser-473 antibody 
(α-P-Akt). Cell-cycle exit dependent from H2O2 exposure was examined by immunoblotting lysates with anti–cyclin D3. 
Anti-actin revealed equal loadings. (B) Day 1 (D1)-differentiated C2C12 cells were exposed to H2O2 450 μM for the 
indicated times. Whole-cell lysates were immunoprecipitated with anti-Ankrd2, -Phospho-Akt substrate, or -Akt1/2 (N 
terminus) antibodies, as indicated. Immunocomplexes and corresponding lysates were resolved on 12% SDS–PAGE and 
immunoblotted as indicated. (C) D1-differentiated C2C12 cells were left untreated or treated with 4 or 6 μM Akt1/2 or 
Akt2 inhibitors and then exposed to H2O2 450 μM for 15 min. Total cell lysates were divided and immunoprecipitated 
with anti–Ankrd2 antibody to check Ankrd2 phosphorylation by Akt, anti-Akt1 and -Akt2 antibodies to verify the 
efficacy of inhibitors.
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binding and phosphorylation occur in the cytoplasm and precede 
nuclear translocation (Figure 5C, IP: α-Ankrd2, WB: α- Akt).
Phosphorylation at Ser-99 prevents the outcome of muscle 
differentiation
Recent studies from Bean and colleagues demonstrate that Ankrd2 
is a negative regulator of muscle differentiation (Bean et al., 2008). 
According to these authors, the overexpression of a WT form of 
Ankrd2 is responsible for a retardation of muscle differentiation. 
Therefore, based on these and on our observation of H2O2 effect 
on cyclin D3 (Figure 4A, anti-cyclin D3), we analyzed whether 
Ankrd2 phosphorylation at Ser- 99 affects the outcome of muscle 
differentiation.
Differentiating C2C12 cells were transfected with empty vector 
and WT or Ser99Ala Ankrd2. Then differentiation of the culture 
was monitored from d1 to d3 of transfection by means of differen-
tiation and muscle-specific markers. As shown in Figure 6, cells 
overexpressing unphosphorylatable Ser99Ala-Ankrd2 showed a 
significant increase in the expression of the muscle-specific tran-
scription factor myogenin, with respect to cells transfected with 
WT Ankrd2 or vector alone. This result was confirmed by both the 
up-regulation of cyclin D3, which withdraws postmitotic cells from 
cell cycle, and the down-regulation of cyclin A, which is instead 
required for S-phase progression. These data were all corrobo-
rated by PCNA (Proliferating Cell Nuclear Antigen) profile, which is 
expressed in proliferating cells and decreases along with differen-
tiation levels. Moreover, the absence of the cleaved form of poly 
ADP-ribose polymerase (PARP) excluded the activation of apop-
totic pathways confirming cell viability.
It is worth noting that Akt phosphorylation/activity (Figure 6, 
anti–P-Akt/Akt) remains comparable among all samples and there-
fore cannot account for the change of the expression of myogenic 
and differentiation markers considered.
FIGURE 5: Oxidative stress induces nuclear translocation of Ankrd2. (A) Day 1 (D1)-differentiating C2C12 myotubes 
were transfected with WT or S99A forms of flag-tagged Ankrd2 and exposed to H2O2 450 μM for 3 h. 
Immunofluorescence was performed using an anti-flag TRITC-conjugated antibody. Cell nuclei were counterstained with 
DAPI. Bar, 10 μM. (B) Statistical analysis (mean values ± SD of counts performed in three different samples). C2C12 
multinucleated myotube counts were performed after 2 d of serum deprivation of cells not transfected (nt), transfected 
with empty vector (ev), wild type (wt), or S99A-mutant Ankrd2. (C) D1-differentiating C2C12 cells were treated with H2O2 
450 μM for 15 min or 3 h or were left untreated, then nuclear and cytoplasmic fractions were purified. Endogenous 
Ankrd2 was next immunoprecipitated by anti–Ankrd2 antibody, run on SDS–PAGE, blotted, and checked for the 
presence of Phospho Akt substrates, Ankrd2, activated and total Akt. Lamin A/C and β-tubulin antibodies were used to 
exclude nuclear or cytoplasmic contamination from cytoplasmic and nuclear extracts, respectively.
FIGURE 6: Failure of phosphorylation of Ankrd2 at Ser-99 promotes 
myogenic differentiation. C2C12 cells at 95% confluence were 
transfected with wild type (wt), S99A mutant flag-Ankrd2, or empty 
vector and allowed to differentiate in differentiating medium for 1, 2, 
and 3 d (d1, d2, and d3). Cell lysates were resolved on SDS–PAGE, 
and the outcome of muscle differentiation was monitored by 
differentiation and cell cycle specific markers myogenin, cyclin A and 
D3, and PCNA (Proliferating Cell Nuclear Antigen). The absence of 
cleaved PARP confirmed cell viability. β-tubulin was shown for equal 
loading. Akt activity was monitored during differentiation by 
anti–phospho Akt Ser-473 (anti P-Akt).
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DISCUSSION
Ankrd2 is a protein specifically expressed in skeletal and cardiac 
muscle. It plays both structural and regulatory roles. Indeed, in 
mature muscle, Ankrd2, which is mainly localized in the I-band of 
the fibers, physically interacts with many structural proteins as titin 
(Miller et al., 2003), myopalladin (a nebulin-anchoring protein+, 
and telethonin (Kojic et al., 2004). It has also been reported, how-
ever, that Ankrd2 can interact with regulatory nuclear proteins as 
promyelocytic leukemia protein, p53, and with transcription fac-
tor YB-1 in vitro (Kojic et al., 2004). In muscle stressed by cardio-
toxin injection or by dry ice, Ankrd2 accumulates in the nuclei of 
sarcomere-damaged myofibers (Tsukamoto et al., 2008). Consis-
tent with Ankrd2 nuclear accumulation in euchromatin, where 
genes are activated, and with its binding to transcription factors, 
it has been suggested that Ankrd2 may act as a transcriptional 
regulator in the nuclei of injured muscles (Tsukamoto et al., 2008). 
Of note, Ankrd2 transcripts and protein increase in response to 
muscle injury, lengthening contractions, and after physical exer-
cise (Barash et al., 2004; Lehti et al., 2009), underscoring the im-
portance of the role of Ankrd2 in the rescue of stressed or dam-
aged muscle cells.
A recent study, performed on C2C12 myoblasts, suggests that 
Ankrd2 contributes to the proliferation and apoptosis machinery 
during myogenic differentiation mainly through the p53 network 
(Bean et al., 2008).
Altogether, these data suggest a dual role for Ankrd2: During 
muscle differentiation, Ankrd2 contributes to regulate the balance 
between proliferation and apoptosis of differentiating myoblasts and 
stabilizes forming myotubes; in addition, Ankrd2 participates in the 
machinery that regulates protection of fibers after muscle injury.
By using a proteomic approach, we have identified Ankrd2 as a 
novel Akt substrate in C2C12 muscle cells. Running the human 
Ankrd2 sequence into the Scansite database predicted Ser-99 to be 
a putative, high-stringency site for Akt phosphorylation. This serine 
lies in a canonical Akt phosphorylation motif, highly conserved in all 
Ankrd2 sequences cloned so far. Indeed, Ser-99 of Ankrd2 is one of 
the more than 500 phospho-Akt motif sites identified in a recent 
large-scale phosphoproteomic analysis, using the phospho-Akt 
substrate antibody to capture peptides (Moritz et al., 2010). By mu-
tational analysis and in vitro kinase assays, we show here that 
Ankrd2 is selectively phosphorylated by Akt at Ser-99 (Figure 2A).
Akt1 and Akt2 are closely related protein kinases with a con-
served phosphorylation motif. They are all activated through similar 
mechanisms involving upstream kinases PI3K and PDK1. The func-
tion of each Akt isoform has been studied in knockout mice as well 
as in isoform-specific knockdowns in cell cultures by specific siRNA. 
These studies reveal the existence of both redundant and distinct 
functions of Akt isoforms. In particular, recent findings demonstrated 
that Akt1 and Akt2 can even have opposing roles. There is little in-
formation, however, about the isoform-specific downstream sub-
strates of Akt. Interestingly, our model provides a further confirma-
tion of the existence of distinct substrates for Akt1 and Akt2. Indeed, 
by both in vitro kinase assays using recombinant active Akt1 or Akt2, 
and by targeting each isoform with siRNAs, we demonstrated that 
Ankrd2 is an Akt2 selective substrate (Figures 2A and 3A). These 
findings are in good agreement with the stronger binding affinity 
shown by Ankrd2 toward Akt2 (Figure 3B), with respect to Akt1 
(lower) or Akt3 (absent); moreover, Akt2 activity is a requisite for its 
binding to Ankrd2 (Figures 2D and 3C). Similar results were obtained 
by means of Akt inhibitors VIII and XII (selective for Akt1/2 and 
Akt2, respectively) both in HEK 293T cells stimulated with insulin 
(Figure 2D), and in C2C12 myoblasts exposed to H2O2 (Figure 4C). 
All in all, these data represent new, important advances in the issue 
of Akt substrate isoform specificity as they establish Akt2 as the 
Ser99-Ankrd2 kinase. This conclusion does not exclude the possibil-
ity, however, that other AGC kinases, with similar substrate specific-
ity, such as SGK (Brunet et al., 2001), might phosphorylate Ankrd2 at 
Ser-99 or at a different epitope, possibly in a different subcellular 
compartment or in varied biological conditions.
A large body of evidence supports the activation of the PI3K/
Akt signaling axis upon the arrival of ROS in several cellular mod-
els, as fibroblasts (Shaw et al., 1998; Wang et al., 2000), vascular 
smooth muscle cells (Ushio-Fukai et al., 1999), and rat primary 
astrocytes (Salsman et al., 2001). The activation of the PI3K/Akt 
pathway might have a pivotal role in controlling several down-
stream antiapoptotic and prosurvival cascades (Mercurio and 
Manning, 1999; Storz and Toker, 2003). Here we demonstrate that 
the PI3K/Akt pathway is also activated by stress in C2C12 myo-
blasts. Moreover, in differentiating C2C12, stress promotes Ankrd2 
phosphorylation by Akt and binding to the kinase (Figure 4, B 
and C). In muscle cells, ROS release occurs in response to me-
chanical stress, contraction, and, after a prolonged muscle exer-
cise, as a consequence of aging and pathological conditions, as 
primary or secondary myopathies. Oxidative stress activates vari-
ous signal transduction pathways, culminating with the activation 
of transcription factors nuclear factor κB and Jun N-terminal ki-
nase. Through these pathways, ROS stimuli lead to the expres-
sion of proteins involved in the detoxification of ROS themselves, 
driving in turn to the rescue of the cells. As the stress becomes 
too long or too intense, however, cells respond by triggering pro-
tein damage, peroxidation of lipids and nucleotides, membranes 
break (Konat, 2003), and eventually apoptosis occurs (Oldham 
and Bowen, 1998; Orzechowski et al., 2002).
In our model, we report that short-term H2O2 stimulation trig-
gers a down-regulation of cyclin D3 (Figure 4A), confirming that 
oxidative stress can delay muscle differentiation (Langen et al., 2002; 
Ardite et al., 2004; Hansen et al., 2007; Zaccagnini et al., 2007).
What is more, the forced expression of an Akt-phosphorylation–
defective Ankrd2 mutant in C2C12 cells, induced to differentiate, 
robustly increased both myotube formation (as assessed by multi-
nucleated cell counting, Figure 5B) and the amount of differentia-
tion and muscle specific markers as cyclin A, cyclin D3, and myo-
genin (Figure 6), suggesting that phosphorylation of Ankrd2 at 
Ser-99 can hamper expression of genes essential for myogenic dif-
ferentiation. Altogether, we conclude that Akt-phosphorylated 
Ankrd2 contributes to the oxidative stress–dependent slackening of 
muscle differentiation.
In unstimulated conditions, Ankrd2 is prominently located in the 
cytoplasm of differentiating cells. H2O2, however, induces Ankrd2 to 
massively redistribute into the nuclear compartment, where its bind-
ing partners are (Kojic et al., 2004). Conversely, the phosphorylation-
defective form of Ankrd2 is unable to relocalize into the nucleus 
upon H2O2 exposure, indicating that Ankrd2 phosphorylation regu-
lates its cellular distribution and, in turn, modulates Ankrd2 binding 
to target proteins, including transcription factors implicated in mus-
cle differentiation (Kojic et al., 2004).
Possibly, upon the arrival of the stimulus, following Ankrd2 
binding to Akt and its subsequent phosphorylation, Ankrd2 
dissociates from this complex to migrate to the nucleus and in-
teract with its effectors. Indeed, although a small amount of Akt 
resides in the nucleus and responds to H2O2 stimulation similarly 
to its cytosolic counterpart, our results demonstrate that Ankrd2 
associates to Akt in the cytoplasm (Figure 5, A–C, and Supple-
mental Figure S1).
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Transient transfections of HEK 293T 
cells were performed by using the calcium 
phosphate method. C2C12 cells were trans-
fected using INGENIO reagent (MirusBio, 
Madison, WI), with the Amaxa electropora-
tor, according to the manufacturer’s instruc-
tions. Where indicated, cells were treated 
with 450 μM H2O2, 1.6 μM insulin, and 
eventually pretreated 30 min before stimu-
lus with 10 μM LY294002, 10 μM Akt inhibi-
tor IV, 5 μM PD 98059, 5 μM rapamycin (all 
obtained from Sigma, St. Louis, MO), 10 μM 
perifosine (Æterna Zentaris, Frankfurt, 
Germany) or with 6 μM Akti 1/2 and Akti 2 
(inhibitor VIII and XII, obtained from Merck-
Millipore, Darmstadt, Germany).
Plasmids
WT, flag-tagged human Ankrd2, cloned in 
pMe-18S, was a gift of K. Shomori (Faculty 
of Medicine, Tottori University, Japan; de-
scribed in Shomori et al., 2007). The cDNA 
was used as template to generate Ser99Ala 
mutant by means of the QuikChange strat-
egy (Stratagene, LaJolla, CA). The following 
mutation primers were used: forward primer, 
GTG CGC AAG ACG gCC CTG GAC CTG 
C; reverse primer, G CAG GTC CAG GGc 
CGT CTT GCG CAC. The mutagenesis 
was verified by a DNA sequencing service 
(BMR, Padua, Italy). Mammalian expression 
vectors containing all the Akt isoforms (HA -Akt1, -Akt2, and -Akt3 
in pCDNA 3), Akt1 and Akt2 specific shRNAs in pLKO were donated 
by A. Toker (Harvard Medical School, Boston, MA).
RNA interference
To produce lentiviral supernatants, 293T cells were cotransfected 
with control or Akt1 or Akt2 shRNA-containing pLKO vectors, VSVG, 
and psPAX2 for 48 h. Where indicated, cells were infected with 
Akt-1 and -2 shRNA lentiviral vectors or empty vector. Forty-eight 
hours after infection, cells were exposed to 2 μg/ml puromycin 
(Sigma), serum starved overnight, and treated with insulin for 30 min. 
Total cell lysates were subjected to immunoblot analysis.
Protein fractionation by MicroRotofor isoelectric focusing
Pellets of C2C12 cells (∼2.5 mg of protein) were dissolved in 2.5 ml of 
isoelectric focusing buffer (7 M urea, 2 M thiourea, 5 mM dithiothre-
itol, 4% [wt/vol] CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulfonate hydrate), and 2% [vol/vol] Pharmalyte, pH 3–10), 
applied to MicroRotofor (Bio-Rad Laboratories, Hercules, CA), and 
electrophoresed according to the manufacturer’s instructions for 
3 h at a constant power of 1 W at 20°C. After electrophoresis, pro-
tein fractions from each compartment were harvested, denatured 
in SDS sample buffer, boiled, and subjected to monodimensional 
electrophoresis.
Preparation of whole-cell extracts and subcellular fractions
Whole cell lysates were prepared by the addition of AT lysis buf-
fer (20 mM Tris-HCl, pH 7.0, 1% Nonidet P-40, 150 mM NaCl, 
10% glycerol, 10 mM EDTA, 20 mM sodium fluoride, 5 mM 
sodium pyrophosphate, 1 mM Na3VO4, 1 mM phenylmethylsul-
fonyl fluoride, 10 μg/ml leupeptin, and 10 μg/ml pepstatin) 
All together, Ankrd2 phosphorylation by Akt should be consid-
ered a limiting factor to muscle differentiation pathways. Indeed, 
the basal phosphorylation of Ankrd2 in unstimulated conditions 
(Figures 1A and 4A) might concur to control muscle differentiation 
rate, ensuring the time needed to allow proper assembly of the 
whole differentiation machinery. Similarly, H2O2-induced Ankrd2 
phosphorylation negatively interferes with muscle differentiation 
pathways. Therefore, during stress, differentiating myoblasts might 
sense the extent of the stress and exploit the negative effects of 
phospho-Ankrd2 to decide whether to drive apoptotic or rescue 
pathways. A model for this mechanism has been proposed in 
Figure 7.
As recently another MARP, Ankrd1, has been identified to be 
point mutated in four different dilated cardiomyopathies (Arimura 
et al., 2009; Moulik et al., 2009), it will be interesting in the future to 
check the phosphorylation of Ser-99 in patients affected by different 
types of musculoskeletal pathologies.
MATERIALS AND METHODS
Cell culture and transfection
C2C12 mouse myoblasts and HEK 293T cells were cultured in 
DMEM high glucose (Invitrogen–Life Technologies, Groningen, 
The Netherlands) supplemented with 10% fetal calf serum 
(EuroClone, Leeds, UK) at 37°C and 5% CO2. Differentiation of 
C2C12 was induced by culturing 100% confluent cells in a differ-
entiating medium consisting of DMEM high glucose plus 2% 
horse serum (EuroClone). Differentiation was quantified by mon-
itoring muscle and cell-cycle specific markers and by counting 
the number of myotubes (with more than two nuclei) present in 
a field under a phase-contrast microscope (Nikon Instruments, 
Calenzano, Italy).
FIGURE 7: Model for inhibition of myogenesis following Ankrd2 phosphorylation by Akt2 
induced by stress conditions. During normal physiological conditions, Ankrd2, which is weakly 
constitutively phosphorylated at Ser-99, might concur to control muscle differentiation rate, 
ensuring the time needed to allow proper assembly of the whole differentiation machinery. 
Under stressful conditions that trigger the production of ROS as H2O2 Akt2 induces a huge 
increase in Ankrd2 phosphorylation at Ser-99, inducing its nuclear translocation and resulting in 
a negative regulation of muscle differentiation pathways.
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